comment-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
6
Favorite

Yujing
2021-07-30

comment

RxSight, Inc. Announces Pricing of Initial Public Offering

ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device c

RxSight, Inc. Announces Pricing of Initial Public Offering

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment（6）

Top
Latest

BBKK
·2021-07-30
Comment
Reply
Like
Report
Fold Replies
- Yujing:
  Comment
  2021-08-09
  Reply
  Report
- Yujing:
  Comment
  2021-08-07
  Reply
  Report
- Yujing:
  Comment
  2021-08-06
  Reply
  Report
View more 2 comments

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":806005280,"tweetId":"806005280","gmtCreate":1627614414840,"gmtModify":1703493405756,"author":{"id":4090414284911250,"idStr":"4090414284911250","authorId":4090414284911250,"authorIdStr":"4090414284911250","name":"Yujing","avatar":"https://static.tigerbbs.com/02fbe7d7a63f23b48d28c901537868da","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>comment</p></body></html>","htmlText":"<html><head></head><body><p>comment</p></body></html>","text":"comment","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":6,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/806005280","repostId":2155138280,"repostType":4,"repost":{"id":"2155138280","kind":"news","pubTimestamp":1627612800,"share":"https://www.laohu8.com/m/news/2155138280?lang=&edition=full","pubTime":"2021-07-30 10:40","market":"us","language":"en","title":"RxSight, Inc. Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2155138280","media":"StreetInsider","summary":"ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device c","content":"<p>ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common stock at a public offering price of $16.00 per share. The gross proceeds to RxSight® from the offering are expected to be $117.6 million, before deducting underwriting discounts and commissions and offering expenses. In addition, RxSight has granted the underwriters a 30-day option to purchase up to an additional 1,102,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. RxSight’s common stock is expected to begin trading on the Nasdaq Global Market on July 30, 2021, under the ticker symbol “RXST.” The offering is expected to close on August 3, 2021, subject to the satisfaction of customary closing conditions.</p>\n<p>J.P. Morgan Securities LLC and BofA Securities, Inc. are acting as joint book-running managers of the offering and as representatives of the underwriters. SVB Leerink LLC is also acting as a book-running manager of the offering. Wells Fargo Securities, LLC is acting as lead manager for the offering. BTIG, LLC is acting as co-manager for the offering.</p>\n<p>A registration statement relating to the shares being sold in this offering has been filed with the Securities and Exchange Commission and was declared effective on July 29, 2021. The offering is being made only by means of a prospectus. When available, a copy of the final prospectus may be obtained by contacting:</p>\n<ul>\n <li>J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, via telephone: +1 (866) 803-9204, or by email at prospectus-eq_fi@jpmchase.com;</li>\n <li>BofA Securities, Inc. Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, by telephone at +1 (800) 294-1322 or by email at dg.prospectus_requests@bofa.com; or</li>\n <li>SVB Leerink LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, telephone: +1 (800) 808-7525, ext. 6105 or by email at syndicate@svbleerink.com.</li>\n <li></li>\n</ul>\n<p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RxSight, Inc. Announces Pricing of Initial Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRxSight, Inc. Announces Pricing of Initial Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 10:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18744480><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18744480\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TERN":"Terns Pharmaceuticals, Inc.","CRCT":"Cricut, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=18744480","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155138280","content_text":"ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common stock at a public offering price of $16.00 per share. The gross proceeds to RxSight® from the offering are expected to be $117.6 million, before deducting underwriting discounts and commissions and offering expenses. In addition, RxSight has granted the underwriters a 30-day option to purchase up to an additional 1,102,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. RxSight’s common stock is expected to begin trading on the Nasdaq Global Market on July 30, 2021, under the ticker symbol “RXST.” The offering is expected to close on August 3, 2021, subject to the satisfaction of customary closing conditions.\nJ.P. Morgan Securities LLC and BofA Securities, Inc. are acting as joint book-running managers of the offering and as representatives of the underwriters. SVB Leerink LLC is also acting as a book-running manager of the offering. Wells Fargo Securities, LLC is acting as lead manager for the offering. BTIG, LLC is acting as co-manager for the offering.\nA registration statement relating to the shares being sold in this offering has been filed with the Securities and Exchange Commission and was declared effective on July 29, 2021. The offering is being made only by means of a prospectus. When available, a copy of the final prospectus may be obtained by contacting:\n\nJ.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, via telephone: +1 (866) 803-9204, or by email at prospectus-eq_fi@jpmchase.com;\nBofA Securities, Inc. Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, by telephone at +1 (800) 294-1322 or by email at dg.prospectus_requests@bofa.com; or\nSVB Leerink LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, telephone: +1 (800) 808-7525, ext. 6105 or by email at syndicate@svbleerink.com.\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.","news_type":1},"isVote":1,"tweetType":1,"viewCount":161,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":5375945,"commentId":"5375945","gmtCreate":1627616095191,"gmtModify":1663231703341,"authorId":4089409912576010,"author":{"id":4089409912576010,"idStr":"4089409912576010","authorId":4089409912576010,"name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":806005280,"objectIdStr":"806005280","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Comment ","text":"Comment ","html":"Comment ","likeSize":0,"commentSize":5,"subComments":[{"id":5468386,"commentId":"5468386","gmtCreate":1628479931829,"gmtModify":1663232110333,"authorId":4090414284911250,"author":{"id":4090414284911250,"idStr":"4090414284911250","authorId":4090414284911250,"name":"Yujing","avatar":"https://static.tigerbbs.com/02fbe7d7a63f23b48d28c901537868da","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":806005280,"objectIdStr":"806005280","type":1,"supId":5375945,"supIdStr":"5375945","prevId":0,"prevIdStr":"0","content":"Comment","text":"Comment","html":"Comment"},{"id":5456709,"commentId":"5456709","gmtCreate":1628344665697,"gmtModify":1663232062831,"authorId":4090414284911250,"author":{"id":4090414284911250,"idStr":"4090414284911250","authorId":4090414284911250,"name":"Yujing","avatar":"https://static.tigerbbs.com/02fbe7d7a63f23b48d28c901537868da","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":806005280,"objectIdStr":"806005280","type":1,"supId":5375945,"supIdStr":"5375945","prevId":0,"prevIdStr":"0","content":"Comment","text":"Comment","html":"Comment"},{"id":5446267,"commentId":"5446267","gmtCreate":1628247307212,"gmtModify":1663232014731,"authorId":4090414284911250,"author":{"id":4090414284911250,"idStr":"4090414284911250","authorId":4090414284911250,"name":"Yujing","avatar":"https://static.tigerbbs.com/02fbe7d7a63f23b48d28c901537868da","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":806005280,"objectIdStr":"806005280","type":1,"supId":5375945,"supIdStr":"5375945","prevId":0,"prevIdStr":"0","content":"Comment","text":"Comment","html":"Comment"},{"id":5430531,"commentId":"5430531","gmtCreate":1628124086301,"gmtModify":1663231947434,"authorId":4090414284911250,"author":{"id":4090414284911250,"idStr":"4090414284911250","authorId":4090414284911250,"name":"Yujing","avatar":"https://static.tigerbbs.com/02fbe7d7a63f23b48d28c901537868da","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":806005280,"objectIdStr":"806005280","type":1,"supId":5375945,"supIdStr":"5375945","prevId":0,"prevIdStr":"0","content":"Comment","text":"Comment","html":"Comment"},{"id":5419514,"commentId":"5419514","gmtCreate":1628038441650,"gmtModify":1663231895841,"authorId":4090414284911250,"author":{"id":4090414284911250,"idStr":"4090414284911250","authorId":4090414284911250,"name":"Yujing","avatar":"https://static.tigerbbs.com/02fbe7d7a63f23b48d28c901537868da","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":806005280,"objectIdStr":"806005280","type":1,"supId":5375945,"supIdStr":"5375945","prevId":0,"prevIdStr":"0","content":"Comment","text":"Comment","html":"Comment"}],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}